Samit Hirawat
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Samit Hirawat is currently an Independent Director at Pacira Biosciences, Inc. starting in 2026.
Formerly, Dr. Hirawat was Chief Medical Officer-Global Drug Development at Bristol Myers Squibb Co. from 2019 to 2025 and Head- Global Oncology Development at Novartis AG from 2017 to 2019.
Education includes an undergraduate degree from SMS Medical College & Hospital.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 12-03-2026 | 31.925 ( 0% ) | 2 M $ | 31-05-2026 | |
| 10-06-2026 | 6.405 ( 0,02% ) | 148 724 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Directeur/Bestuurslid | 27-01-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Hoofd Techniek/Wetenschap/O&O | 01-08-2025 |
| NOVARTIS AG | Corporate Officer/Principal | 01-06-2019 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
SMS Medical College & Hospital
SMS Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau